Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy

BACKGROUND: Metastatic breast cancer (mBC) is a complex and life-threatening disease and although it is difficult to cure, patients can benefit from sequential anticancer treatment, including endocrine therapy, targeted therapy and cytotoxic chemotherapy. The patient-derived xenograft (PDX) model is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seongyeong, Shin, Dongjin, Min, Ahrum, Kim, Minjung, Na, Deukchae, Lee, Han-Byeol, Ryu, Han Suk, Yang, Yaewon, Woo, Go-Un, Lee, Kyung-Hun, Lee, Dae-Won, Kim, Tae-Yong, Lee, Charles, Im, Seock-Ah, Kim, Jong-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789010/
https://www.ncbi.nlm.nih.gov/pubmed/33407601
http://dx.doi.org/10.1186/s12967-020-02607-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789010/
https://www.ncbi.nlm.nih.gov/pubmed/33407601
http://dx.doi.org/10.1186/s12967-020-02607-2

Ejemplares similares